Vivex Biologics, Inc., a leading Regenerative Medicine company, announced that Peter Wehrly has been appointed the new CEO. Mr. Wehrly is a seasoned leader in the medical device and biotech industries that consistently delivers top-line growth and operational efficiencies.

Mr. Wehrly is the former CEO and serves as the current Chairman of the Board of Synaptive Medical, a privately held Toronto-based company that focuses on uniting highly innovative technology with the medical device industry for neuro-cranial and spinal markets. Wehrly served in several leadership positions at Covidien including Group President heading the global businesses in Western Europe, Japan, Canada, Australia and New Zealand. Prior to joining Covidien, he held various general management positions within Medtronic Inc., including Senior Vice-President Medtronic, President Spinal & Biologics and President of Medtronic Sofamor Danek. Additionally, Wehrly spent 17 years with DePuy Orthopedics, a Johnson & Johnson company where he served numerous roles of increasing responsibilities including VP of Sales & Marketing and President of DePuy OrthoTech.

“Today’s announcement underscores our commitment to finding a leader who can build on the Company’s current momentum and opportunities in the years ahead,” said Vivex Biologics Chairman John McCallum. “After an extensive search, we have found that leader in Peter. His many years of experience and solid understanding of the medical device and bio-tech markets that Vivex Biologics competes in, make him well qualified to lead the Company.”

“I am excited to join Vivex Biologics,” said Peter Wehrly. “It is an honor to assume this leadership role, particularly at a time when the company is so well positioned to launch and develop new treatments to improve patient’s lives. I look forward to working with the great team at Vivex Biologics as we continue to shape the company for the future.”

Wehrly has held numerous board positions at for profit and not-for-profit organizations. He earned his BS in Management from Ball State University and has completed several advanced management programs including a program at the IMD International School of Management in Lausanne, Switzerland.